ABL1 INHIBITOR FOR TREATING AND PREVENTING OCULAR NEOVASCULARISATION

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP15700791.5

公开号：

EP3096780A1

申请日:

2015.01.20

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

The present invention relates to an Abelson murine leukaemia viral oncogene homolog 1 (ABL1) inhibitor for use in the treatment of ocular neovascularisation associated with a non-cancerous condition. The invention also relates to the use of an ABL1 inhibitor as a complementary therapy with VEGF or VEGF receptor inhibitor treatment and provides pharmaceutical compos itions and kits comprising one or both inhibitors.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/